With a grant from the ACR’s Rheumatology Research Foundation, Nancy J. Olsen, MD, hopes to discover how methotrexate interacts with immune system cells and ultimately helps to control the system’s attack on joints
ACR Advances Legislation to Increase Patients’ Access to Biologic Drugs to Treat Rheumatoid Arthritis and Other Conditions
The Patients’ Access to Treatments Act of 2013 would prevent insurance companies from tacking on an additional cost-sharing fee for the specialty medications
ACR/ARHP Annual Meeting 2012: Fatigue for People with Rheumatoid Arthritis Rooted in Physiological and Psychological Factors
Researchers find that genes, gender, and cognition all contribute to fatigue in rheumatoid arthritis (RA)
First Annual Rheumatoid Awareness Day to Be Held February 2
New day of action and outreach aims to spread awareness of rheumatoid arthritis
ACR/ARHP Annual Meeting 2012: Early Signs of Rheumatoid Arthritis May Appear Outside the Joints
Evidence that suggests rheumatoid arthritis (RA) starts in mucosal sites such as the oral cavity and lung may lead to improved treatment and prevention of the disease
Gene to Block TNF Linked to Multiple Sclerosis but not Rheumatoid Arthritis
A single nucleotide polymorphism (SNP) in the
gene encoding the receptor for tumor necrosis factor (TNF) 1 is associated with multiple sclerosis (MS) but not rheumatoid arthritis (RA) or other autoimmune conditions.
Survivin Essential for the Maturation of Antigen Presenting Cells in Rheumatoid Arthritis Patients
In patients with RA, survivin is essential for the survival of leukocytes as they differentiate and mature into dendritic cells, thereby raising it as a potential therapeutic target.
Foundation Researcher Studies Role of IL-17 in Rheumatoid Arthritis
A grant from the American College of Rheumatology (ACR)’s Rheumatology Research Foundation has helped Shiva Shahrara, PhD, conduct research into the molecule, IL-17, that plays a role in recruiting myeloid cells to migrate from the blood to the joint and perpetuating vascularization
Coding Corner Question: January
Test your coding knowledge for identifying the determining factors for determining the level of risk in the medical decision making for a patient with rheumatoid arthritis.
Coding Corner Answer: January Coding Challenge
Identifying multiple determining factors—including prescription drug management, drug therapy, and chronic illness with severe exacerbation, progression, or side effects to treatment—in determining the level of risk in the medical decision making for a patient with rheumatoid arthritis
- « Previous Page
- 1
- …
- 23
- 24
- 25
- 26
- 27
- …
- 45
- Next Page »